Data across all dementia [5], from AD [6–8] and from PDD [9], suggests an effect of acetylcholinesterase inhibitors (AChEIs) to reduce mortality; however, there is no such evidence for DLB despite its relatively high prevalence and poor prognosis. The gene discussed is ACHE; the disease is Lewy body dementia.